MAZE
Maze Therapeutics, Inc. · Healthcare
President, R&D & CMO Harold Bernstein sold $446K of Maze Therapeutics, Inc.
Sold$445,621
$27.61Price
16,142Shares
−100%Stake
What MAZE did after the filing
- The stock from Tue, Aug 18 open, $27.89
- −6.6%
- S&P 500, same days
- +0.3%
27 of 30 trading days so far, to the Sep 25 close.
Traded Thu, Aug 13. Filed Fri, Aug 14, 4:54 PM ET, after the close. Returns use the Aug 18 open and the Sep 25 close. Not investment advice.